Publicacións en colaboración con investigadores/as de Hospital Universitario de la Princesa (17)

2023

  1. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  2. REDES Study: Mepolizumab Is Effective in Patients With Severe Asthma and Comorbid Nasal Polyps

    Journal of Investigational Allergology and Clinical Immunology

  3. Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain

    Open Respiratory Archives, Vol. 5, Núm. 3

  4. Validation of the Asthma Impairment and Risk Questionnaire in Spain: A Useful Tool for Assessing Asthma Control in Adolescents and Adults

    Journal of Investigational Allergology and Clinical Immunology

  5. What's New in the 2022 Consensus for Severe Asthma in Adults

    Archivos de Bronconeumologia

2022

  1. Consensus document for severe asthma in adults. 2022 update

    Open Respiratory Archives, Vol. 4, Núm. 3

  2. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  3. How to Approach Non Eosinophilic Asthma? Results of a Survey Conducted by the SEPAR Emerging Asthma Group

    Open Respiratory Archives, Vol. 4, Núm. 1

  4. Monoclonal antibody treatment for severe uncontrolled asthma in Spain: analytical map

    Journal of Asthma, Vol. 59, Núm. 10, pp. 1997-2007

  5. Support for Home Administration of Biological Therapy in Patients With Severe Asthma: BioCart©

    Journal of Investigational Allergology and Clinical Immunology

2021

  1. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27

  2. SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases

    Open Respiratory Archives, Vol. 3, Núm. 2

2020

  1. Consensus Document for Severe Asthma in Adults. 2020 Update

    Open Respiratory Archives, Vol. 2, Núm. 3, pp. 158-174

  2. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

2018

  1. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

  2. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

  3. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis

    Respiration, Vol. 96, Núm. 5, pp. 406-416